insider24.ch
Back to the feed

Shareholding disclosure

Deka Investment GmbH

inSanthera Pharmaceuticals Holding AG

Declared position

5%

Threshold

Fell below threshold

Timeline

Published

15.02.2007

Transaction

—

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold5%

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

T4577D4369

Beneficial owner

Deka Investment GmbH

Declared address

Deka Investment GmbH, Frankfurt a. M.

Deka Investment GmbH hält über folgende Fonds: Deka Pharma Tech, Deka Bio Tech, Deka Schweiz und Deka Institutionell Aktien Europa.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open